PCN34 Comparative Effectiveness of Docetaxel and Paclitaxel in Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Previous Chemotherapy: Propensity Score-Matching Analyses from Attraction-3 Trial
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.126
https://www.valueinhealthjournal.com/article/S1098-3015(21)00343-0/fulltext
Title :
PCN34 Comparative Effectiveness of Docetaxel and Paclitaxel in Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Previous Chemotherapy: Propensity Score-Matching Analyses from Attraction-3 Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00343-0&doi=10.1016/j.jval.2021.04.126
First page :
Section Title :
Open access? :
No
Section Order :
10691